T-REX BIO TEAMS WITH WESTWOOD & WILSHIRE TO FILL HEAD OF COMPUTATIONAL BIOLOGY ROLE

South San Francisco, California, April 12— T-Rex Bio, a discovery-stage biotechnology company, has hired Christopher Yohn as the Head of Computational Biology. The company is dedicated to discovering and developing a new class of immuno-regulatory therapeutics which reset the immune system to restore health with regulatory T cells (T-regs).

Dr. Yohn joins T-Rex from UNITY Biotechnology, where he served as Senior Director of Discovery Technologies after being promoted from director roles in bioinformatics and biomarkers. Dr. Yohn previously had stints at Sapphire Energy and Farville. He received his Ph.D. at Scripps Research before completing his postdoc at The Skirball Institute at NYU Medical Center. Dr. Yohn has published over 20 articles and has 7 patents issued or pending.

The search was successfully led by James Reynolds for Westwood & Wilshire’s Life Sciences Practice.

Westwood & Wilshire is a retained executive search firm that recognizes people as any organization’s top asset. The firm has delivered premier talent to many of the world’s most innovative companies in life sciences, healthcare, and advanced technology. Westwood & Wilshire specializes in bringing top-tier candidates at the mid-management to C-Suite level to clients ranging from VC backed start-ups to mid-sized commercial entities. The firm has offices in Los Angeles, Silicon Valley, Scottsdale, and Connecticut serving clients worldwide.